1. Home
  2. GSM vs ARVN Comparison

GSM vs ARVN Comparison

Compare GSM & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ferroglobe PLC

GSM

Ferroglobe PLC

HOLD

Current Price

$3.81

Market Cap

964.9M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$11.04

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSM
ARVN
Founded
2015
2015
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
964.9M
781.0M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
GSM
ARVN
Price
$3.81
$11.04
Analyst Decision
Strong Buy
Buy
Analyst Count
1
20
Target Price
$6.00
$15.35
AVG Volume (30 Days)
1.1M
770.9K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
1.51%
N/A
EPS Growth
N/A
58.84
EPS
N/A
N/A
Revenue
N/A
$262,600,000.00
Revenue This Year
$23.36
N/A
Revenue Next Year
$17.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.97
$5.90
52 Week High
$5.74
$14.22

Technical Indicators

Market Signals
Indicator
GSM
ARVN
Relative Strength Index (RSI) 29.63 33.59
Support Level $3.59 $9.02
Resistance Level $4.56 $14.03
Average True Range (ATR) 0.25 0.67
MACD -0.11 -0.29
Stochastic Oscillator 4.89 9.10

Price Performance

Historical Comparison
GSM
ARVN

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: